Found: 79
Select item for more details and to access through your institution.
Effects of zoledronic acid and exemestane combination therapy on immune function, sex hormones, bone markers, and clinical efficacy in hormone receptor-positive breast cancer patients.
- Published in:
- European Journal of Gynaecological Oncology, 2024, v. 45, n. 2, p. 66, doi. 10.22514/ejgo.2024.029
- By:
- Publication type:
- Article
Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study.
- Published in:
- Oncology Research & Treatment, 2018, v. 41, n. 3, p. 93, doi. 10.1159/000485566
- By:
- Publication type:
- Article
Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Long-term efficacy and safety of exemestane in the treatment of breast cancer.
- Published in:
- Patient Preference & Adherence, 2013, v. 7, p. 245, doi. 10.2147/PPA.S42223
- By:
- Publication type:
- Article
Everolimus and exemestane in long survival hormone receptor positive male breast cancer: case report.
- Published in:
- BMC Research Notes, 2016, v. 9, p. 1, doi. 10.1186/s13104-016-2301-2
- By:
- Publication type:
- Article
Efficacy and safety of everolimus in hormone receptor positive breast cancer in a developing country: Real-life single institutional experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Triptorelin: A Review of its Use as an Adjuvant Anticancer Therapy in Early Breast Cancer.
- Published in:
- Drugs, 2017, v. 77, n. 18, p. 2037, doi. 10.1007/s40265-017-0849-3
- By:
- Publication type:
- Article
Paget's Disease of the Male Breast.
- Published in:
- International Journal of Gerontology, 2022, v. 16, n. 4, p. 407, doi. 10.6890/IJGE.202210_16(4).0020
- By:
- Publication type:
- Article
Artificial sex reversal of white grouper (Epinephelus aeneus) utilizing aromatase inhibitor (Fadrozole).
- Published in:
- Aquaculture Research, 2019, v. 50, n. 5, p. 1539, doi. 10.1111/are.14030
- By:
- Publication type:
- Article
Targeting the mammalian target of rapamycin pathway with everolimus: Implications for the management of metastatic breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2015, v. 21, n. 6, p. 433, doi. 10.1177/1078155214540732
- By:
- Publication type:
- Article
The Role of Phorbol Diesters in Mediating Human Placental Aromatase Cytochrome P450 Activity.
- Published in:
- Applied Biosciences, 2022, v. 1, n. 3, p. 279, doi. 10.3390/applbiosci1030017
- By:
- Publication type:
- Article
Development and evaluation of exemestane-loaded lyotropic liquid crystalline gel formulations.
- Published in:
- BioImpacts, 2017, v. 7, n. 4, p. 227, doi. 10.15171/bi.2017.27
- By:
- Publication type:
- Article
Everolimus in Combination with Exemestane: A Review of its Use in the Treatment of Patients with Postmenopausal Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
DETERMINATION OF LETROZOLE, ANASTROZOLE AND EXEMESTANE BY CAPILLARY ZONE ELECTROPHORESIS.
- Published in:
- Studia Universitatis Babes-Bolyai, Chemia, 2017, v. 62, n. 3, p. 251, doi. 10.24193/subbchem.2017.3.21
- By:
- Publication type:
- Article
Effectiveness of the aromatase (P450 Arom) inhibitors Letrozole and Exemestane for masculinization of red tilapia (Oreochromis spp.).
- Published in:
- Revista Colombiana de Ciencias Pecuarias, 2014, v. 27, n. 1, p. 47, doi. 10.17533/udea.rccp.324878
- By:
- Publication type:
- Article
Validation of RP-HPLC method for determination of exemestane and its impurities in pharmaceutical dosage forms.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2016, v. 62, p. 213
- By:
- Publication type:
- Article
Guideline adds aromatase inhibitor for breast cancer prevention.
- Published in:
- Formulary, 2013, v. 48, n. 8, p. 243
- Publication type:
- Article
Management of patients with hormone receptor-positive breast cancer with visceral disease: challenges and treatment options.
- Published in:
- Cancer Management & Research, 2015, v. 7, p. 37, doi. 10.2147/CMAR.S72592
- By:
- Publication type:
- Article
Microbial transformation of anti-cancer steroid exemestane and cytotoxicity of its metabolites against cancer cell lines.
- Published in:
- Chemistry Central Journal, 2013, v. 7, n. 1, p. 1, doi. 10.1186/1752-153X-7-57
- By:
- Publication type:
- Article
Evaluating the 21-gene assay Recurrence Score as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer.
- Published in:
- International Journal of Clinical Oncology, 2014, v. 19, n. 4, p. 607, doi. 10.1007/s10147-013-0614-x
- By:
- Publication type:
- Article
Tucidinostat Plus Exemestane as a Neoadjuvant in Early-Stage, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 6, p. e763, doi. 10.1093/oncolo/oyae033
- By:
- Publication type:
- Article
Oral Care Evaluation to Prevent Oral Mucositis in Estrogen Receptor‐Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care‐BC): A Randomized Controlled Phase III Trial.
- Published in:
- Oncologist, 2020, v. 25, n. 2, p. e223, doi. 10.1634/theoncologist.2019-0382
- By:
- Publication type:
- Article
Everolimus plus Exemestane for Hormone Receptor‐Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO‐2.
- Published in:
- Oncologist, 2019, v. 24, n. 7, p. 893, doi. 10.1634/theoncologist.2018-0407
- By:
- Publication type:
- Article
Impact of Comorbidities and Age on Cause‐Specific Mortality in Postmenopausal Patients with Breast Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 7, p. e467, doi. 10.1634/theoncologist.2018-0010
- By:
- Publication type:
- Article
Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting.
- Published in:
- Oncologist, 2017, v. 22, n. 6, p. 648, doi. 10.1634/theoncologist.2016-0461
- By:
- Publication type:
- Article
Clinical Trial Results. A Pilot Study of Estradiol Followed by Exemestane for Reversing Endocrine Resistance in Postmenopausal Women With Hormone Receptor-Positive Metastatic Breast Cancer.
- Published in:
- Oncologist, 2014, v. 19, n. 11, p. 1126, doi. 10.1634/theoncologist.2014-0306
- By:
- Publication type:
- Article
Bosutinib in Combination With the Aromatase Inhibitor Exemestane: A Phase II Trial in Postmenopausal Women With Previously Treated Locally Advanced or Metastatic Hormone Receptor-Positive/HER2-Negative Breast Cancer.
- Published in:
- Oncologist, 2014, v. 19, n. 4, p. 346, doi. 10.1634/theoncologist.2014-0022
- By:
- Publication type:
- Article
Neoadjuvant endocrine therapy with exemestane followed by response‐guided combination therapy with low‐dose cyclophosphamide in postmenopausal patients with estrogen receptor‐positive breast cancer: A multicenter, open‐label, phase II study
- Published in:
- Cancer Medicine, 2018, v. 7, n. 7, p. 3044, doi. 10.1002/cam4.1600
- By:
- Publication type:
- Article
Cancer Diagnostic and Predictive Biomarkers 2018.
- Published in:
- BioMed Research International, 2019, p. 1, doi. 10.1155/2019/3879015
- By:
- Publication type:
- Article
Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analogues.
- Published in:
- Breast Journal, 2019, v. 25, n. 6, p. 1310, doi. 10.1111/tbj.13474
- By:
- Publication type:
- Article
Efficacy and safety of adjuvant endocrine therapy in premenopausal patients with early‐stage hormone receptor‐positive breast cancer: A meta‐analysis of randomized controlled trials.
- Published in:
- Breast Journal, 2019, v. 25, n. 6, p. 1297, doi. 10.1111/tbj.13465
- By:
- Publication type:
- Article
Observational study of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer.
- Published in:
- Acta Oncologica, 2019, v. 58, n. 3, p. 385, doi. 10.1080/0284186X.2019.1566771
- By:
- Publication type:
- Article
Tumor reduction and symptom relief after electrochemotherapy in a patient with aggressive fibromatosis – a case report.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: A Dutch TEAM trial analysis.
- Published in:
- Acta Oncologica, 2015, v. 54, n. 3, p. 349, doi. 10.3109/0284186X.2014.964809
- By:
- Publication type:
- Article
The Prognostic Values of Androgen Receptor in Breast Cancer: A Hospital-Based Retrospective and Propensity Score--Matched Cohort.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2023, v. 147, n. 9, p. 1075, doi. 10.5858/arpa.2021-0590-OA
- By:
- Publication type:
- Article
Clinical utility of exemestane in the treatment of breast cancer.
- Published in:
- International Journal of Women's Health, 2015, v. 7, p. 551, doi. 10.2147/IJWH.S69475
- By:
- Publication type:
- Article
Advances in Association of Estrogen and Human Non-small Cell Lung Cancer.
- Published in:
- Chinese Journal of Lung Cancer, 2015, v. 18, n. 5, p. 315, doi. 10.3779/j.issn.1009-3419.2015.05.10
- By:
- Publication type:
- Article
Comparison of Treatments for HR+ Early Breast Cancer.
- Published in:
- MD Conference Express, 2014, v. 14, n. 14, p. 9, doi. 10.1177/155989771414003
- By:
- Publication type:
- Article
Effect of Aromatase Inhibition (Exemestane) on Urine Concentration of Osteoprotegerin in Healthy Postmenopausal Women.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 2, p. 209, doi. 10.1002/jcph.1519
- By:
- Publication type:
- Article
Progression-free or overall survival...revisited in BOLERO-2.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Long‐term effect of exemestane therapy on bone mineral density supported by bisphosphonates: Results of 5‐year adjuvant treatment in postmenopausal women with early‐stage breast cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2018, v. 14, n. 5, p. e238, doi. 10.1111/ajco.13034
- By:
- Publication type:
- Article
Subacute cutaneous lupus erythematosus following ribociclib therapy for metastatic breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1793, doi. 10.1177/10781552231185855
- By:
- Publication type:
- Article
Exemestane induced cholestatic liver injury – A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 1029, doi. 10.1177/1078155220957726
- By:
- Publication type:
- Article
Lack of everolimus diffusion in pleural fluid during pleural progression of breast cancer: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 1, p. 235, doi. 10.1177/1078155220927771
- By:
- Publication type:
- Article
Safety of trastuzumab after trastuzumab emtansine-induced nodular regenerative hyperplasia: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1780, doi. 10.1177/1078155220910252
- By:
- Publication type:
- Article
Effect of prior chemotherapy regimens on the efficacy of endocrine therapy within a German cohort of the TEAM trial.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 1, p. 117, doi. 10.1007/s00432-013-1551-9
- By:
- Publication type:
- Article
Exemestane Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells and Promoting the Secretion of Interleukin 10.
- Published in:
- Journal of Immunology Research, 2017, p. 1, doi. 10.1155/2017/3072745
- By:
- Publication type:
- Article
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus.
- Published in:
- BioMed Research International, 2018, v. 2018, p. 1, doi. 10.1155/2018/3756981
- By:
- Publication type:
- Article
Impact of the OATP1B1 c.521T>C single nucleotide polymorphism on the pharmacokinetics of exemestane in healthy post-menopausal female volunteers.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2017, v. 42, n. 5, p. 547, doi. 10.1111/jcpt.12569
- By:
- Publication type:
- Article
A comparison of the intrasubject variation in drug exposure between generic and brand-name drugs: a retrospective analysis of replicate design trials.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 81, n. 4, p. 667, doi. 10.1111/bcp.12828
- By:
- Publication type:
- Article